HCA Healthcare (HCA) EBIT Margin (2010 - 2026)

HCA Healthcare has disclosed EBIT Margin across 17 years of filings, most recently posting 2.96% for Q1 2026.

• In Q1 2026, EBIT Margin rose 532.0% year-over-year to 2.96%; the TTM figure through Mar 2026 stood at 9.9% (up 329.0% YoY), while the FY2025 annual figure was 2.73%, up 20.0% from the prior year.
• EBIT Margin rose to 2.96% in Q1 2026, from 24.72% in the prior quarter.
• Over the last five years, EBIT Margin for HCA reached as high as 2.31% in Q2 2025 and fell as low as 25.84% in Q4 2024.
• The 5-year median for EBIT Margin is 6.3% (2022), against an average of 8.89%.
• Annual changes were most pronounced in 2023 — EBIT Margin slumped 1268 bps — and 2025, when it surged 562 bps.
• A 5-year view of EBIT Margin shows it stood at 5.88% in 2022, then slumped by 216 bps to 18.56% in 2023, then plunged by 39 bps to 25.84% in 2024, then gained by 4 bps to 24.72% in 2025, then surged by 88 bps to 2.96% in 2026.
• According to Business Quant data, EBIT Margin over the past three periods registered 2.96%, 24.72%, and 9.1% for Q1 2026, Q4 2025, and Q3 2025 respectively.